A 28-year-old woman with SLE presents with a photosensitive malar rash, arthralgia, and proteinuria. Laboratory investigations reveal positive ANA (1:640, homogeneous pattern), anti-dsDNA antibodies, and low C3/C4 levels. Regarding the immunopathology of SLE, all of the following statements are correct EXCEPT:

Explanation

## Immunopathology of SLE — Antibody Profiles and Specificity ### ANA and Anti-dsDNA in SLE **Key Point:** Anti-dsDNA antibodies are highly specific for SLE (95–98% specificity) and strongly correlate with lupus nephritis activity. When anti-dsDNA titers rise, renal flares are imminent; falling titers suggest remission [cite:Robbins 10e Ch 4]. **High-Yield:** ANA is sensitive (>95%) but NOT specific for SLE — it is positive in many autoimmune conditions (Sjögren, RA, scleroderma, drug-induced lupus). The homogeneous pattern (anti-histone + anti-dsDNA) is characteristic of SLE, but peripheral/nucleolar patterns suggest other diagnoses. ### Why Anti-Histone Antibodies Are NOT the Most Sensitive Marker **Clinical Pearl:** Anti-histone antibodies are present in **60–70%** of SLE cases, NOT >95%. They are MORE sensitive for **drug-induced lupus** (>95%), where they occur without anti-dsDNA. In idiopathic SLE, anti-dsDNA is more specific and clinically relevant. **Mnemonic:** **SAND** = **S**ensitivity **A**nd **N**ot **D**sDNA — anti-histone is sensitive but not as discriminating as anti-dsDNA in SLE. ### Immune Complex Deposition in Lupus Nephritis | Feature | Detail | |---------|--------| | **Hypersensitivity type** | Type III (immune complex-mediated) | | **Complement pathway** | Classical pathway (C1q → C4 → C3 depletion) | | **Glomerular pattern** | Wire-loop lesions, subendothelial deposits ("full house" on immunofluorescence) | | **Correlation** | Low C3/C4 = active immune complex disease | **Key Point:** The "full house" immunofluorescence pattern (IgG, IgA, IgM, C3, C1q all positive) is pathognomonic for lupus nephritis and reflects Type III hypersensitivity with complement activation. ### Correct Answer Rationale Option 3 (anti-histone antibodies being the most sensitive marker for SLE with >95% prevalence) is **incorrect**. Anti-histone sensitivity in SLE is 60–70%; their high sensitivity (>95%) is seen in **drug-induced lupus**, not idiopathic SLE. This is a classic NEET PG trap — confusing the sensitivity profile of anti-histone antibodies across different lupus phenotypes.